AI Tool Shows Promising Results in Assessing Parkinson’s Severity

University of Rochester researchers have unveiled an innovative online tool, harnessing artificial intelligence (AI), which enables individuals with Parkinson’s disease (PD) to assess the severity of their symptoms remotely and swiftly.

Continue ReadingAI Tool Shows Promising Results in Assessing Parkinson’s Severity

New ALS Treatment on the Horizon: ‘Velcro-like’ Protein Molecule Identified

Researchers have identified a protein, alpha 5 integrin, which is linked to the progression of amyotrophic lateral sclerosis (ALS). The protein was consistently found in high concentrations around damaged motor neurons in ALS patients and mouse models. By blocking this protein in mice, the disease's progression was slowed, and motor skills improved.

Continue ReadingNew ALS Treatment on the Horizon: ‘Velcro-like’ Protein Molecule Identified

New Software Offers Insight into Calcium’s Role in Heart Diseases and Aids Medical Research

Researchers from UC Davis and the University of Oxford have developed SparkMaster 2, a cutting-edge software to automatically analyze calcium activity in cells. This breakthrough promises to significantly aid medical research. New Software Offers Insight into Calcium's Role in Heart Diseases and Aids Medical Research

Continue ReadingNew Software Offers Insight into Calcium’s Role in Heart Diseases and Aids Medical Research

Biohaven’s New Epilepsy Treatment Shows Promising Results in Phase 1 Studies

Biohaven, has unveiled optimistic data from its recent Phase 1 EEG biomarker study of BHV-7000, a novel epilepsy treatment. The research centered on assessing qualitative EEG changes post-administration of BHV-7000 in different doses, providing an insight into its potential effects.

Continue ReadingBiohaven’s New Epilepsy Treatment Shows Promising Results in Phase 1 Studies

Newly Discovered Bird Flu Mutation Sparks Global Pandemic Fear

A newly discovered mutation of the avian flu virus in Chinese poultry farms has caused worldwide alarm, as scientists warn it could increase the risk of the virus transmitting to humans on a wider scale. These changes could potentially make the disease more transmissible among humans.

Continue ReadingNewly Discovered Bird Flu Mutation Sparks Global Pandemic Fear

FDA has issued a report on risks of virtual reality AR/VR medical devices

The U.S. Food and Drug Administration recently published a report highlighting the benefits and risks of emerging augmented and virtual reality (AR/VR) medical devices. While these tools offer advancements in medical care delivery, the FDA emphasized several potential risks.

Continue ReadingFDA has issued a report on risks of virtual reality AR/VR medical devices

BioMarin’s Revolutionary Gene Therapy, Roctavian, Launches in Europe

BioMarin Pharmaceutical has introduced its gene therapy, Roctavian, in Europe, marking a significant breakthrough for severe haemophilia A patients. The new gene therapy, first administered in Germany, enables patients to naturally produce the clotting factor VIII protein.

Continue ReadingBioMarin’s Revolutionary Gene Therapy, Roctavian, Launches in Europe

Roche’s Alecensa Shows Promise in Early-Stage Lung Cancer Treatment

Roche has announced encouraging results from a Phase 3 trial for its drug, Alecensa, in treating early-stage non-small cell lung cancer (NSCLC) with ALK-positive tumors. The ALINA trial showed that Alecensa might be more effective than standard chemotherapy.

Continue ReadingRoche’s Alecensa Shows Promise in Early-Stage Lung Cancer Treatment

FDA Grants Orphan Drug Designation to Bexmarilimab for Acute Myeloid Leukaemia

FDA has given Orphan Drug Designation to Faron Pharmaceuticals' bexmarilimab, a treatment designed for acute myeloid leukaemia. This breakthrough in drug designation is set to bring advantages in clinical development and commercialisation,

Continue ReadingFDA Grants Orphan Drug Designation to Bexmarilimab for Acute Myeloid Leukaemia

Opioid Vaccines Near Human Trials: Targeting Fentanyl and Heroin

A groundbreaking advance in the fight against the opioid epidemic is unfolding at the University of Montana. Vaccines targeting fatal opioids, fentanyl and heroin, are set to commence human trials in early 2024. Researchers, are on the brink of testing vaccines designed to prevent fentanyl and heroin overdoses in humans. 

Continue ReadingOpioid Vaccines Near Human Trials: Targeting Fentanyl and Heroin

The European Commission grants approval to Merck’s Keytruda for gastric cancer

The European Commission has approved Merck’s Keytruda, in combination with other drugs, for the treatment of gastric or gastroesophageal junction adenocarcinoma. Keytruda, an anti-PD-1 therapy, is the inaugural immunotherapy to be endorsed in the EU for this group of patients.

Continue ReadingThe European Commission grants approval to Merck’s Keytruda for gastric cancer

UC Irvine Experts Issue Warning About Weight Loss Drugs, GLP-1RAs, for Children

Researchers from the University of California have issued a warning about the potential dangers of GLP-1RAs, commonly used in weight loss drugs such as Ozempic and Wegovy - for children and adolescents. The drugs, increasingly used to treat childhood obesity and type 2 diabetes, may have unintended and adverse impacts on pediatric health.

Continue ReadingUC Irvine Experts Issue Warning About Weight Loss Drugs, GLP-1RAs, for Children

Regard’s GPT-4 Enhanced Features Transform Clinical Documentation and Operations

Regard, an AI software company, has collaborated with OpenAI to introduce new functionalities in their core product and launch a chatbot named Max, powered by OpenAI's GPT-4. Aimed at revolutionizing clinical workflows, these features are being tested across multiple health systems in the U.S.

Continue ReadingRegard’s GPT-4 Enhanced Features Transform Clinical Documentation and Operations

Stanford Study Reveals BeMe Health’s Pivotal Role in Teen Mental Support

A Stanford-backed study on the BeMe Health app, tailored for teens, highlights substantial user engagement and positive mental health impact. Of over 13,000 participants, a significant majority screened positively for depression and anxiety, finding solace in the platform's evidence-based content.

Continue ReadingStanford Study Reveals BeMe Health’s Pivotal Role in Teen Mental Support

Obesity Drug Wegovy Shows Positive Results for Heart Failure, Study Finds

According to the phase 3 STEP HFpEF study published in The New England Journal of Medicine, the popular diabetes and weight loss drug Wegovy (semaglutide) significantly reduced symptoms of a common type of heart failure and led to increased weight loss in obese individuals.

Continue ReadingObesity Drug Wegovy Shows Positive Results for Heart Failure, Study Finds

Study Reveals ChatGPT’s Impressive Accuracy in Transforming Clinical Practice

Recent research unveils ChatGPT's groundbreaking potential in the medical field. The AI chatbot demonstrates a notable 72% accuracy rate in clinical decisions. The study shows how ChatGPT is reshaping modern clinical practices.

Continue ReadingStudy Reveals ChatGPT’s Impressive Accuracy in Transforming Clinical Practice